Venus Concept Inc. Announces Review of Strategic Alternatives
TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
NEW YORK, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage...
BENTONVILLE, Ark., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Glucose Health, Inc., the pioneer in delicious manufacturing prebiotic soluble fiber enriched...
– Funding from existing investors, including EcoR1 Capital, an affiliate of Deerfield Management and Suvretta Capital – – Pro forma...
PRESS RELEASE Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted...
SparingVision Reaches Final Dose Escalation Step in PRODYGY Trial with SPVN06 for retinitis pigmentosa Positive recommendation received from the Data...
ROSCREA, Ireland, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative...
Acquisition Solidifies Tilray’s Leadership Position in Cannabis Beverages with ~40% Market Share Truss Facility Bolsters Tilray’s Beverage Operations in Canada...
FDA requesting clarifications around chemistry, manufacturing and controls and additional information related to immunogenicityCRL does not impact commercial availability of...
Partners able to claim up to 30% tax reliefCAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE)...
TerrAscend expands its Valhalla product lineup to include one of the first 100mg edibles in The Keystone StateTORONTO, Jan. 24,...
LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient...
OTTAWA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The EmpowerHER Leadership Network proudly unveils its innovative networking platform, marking a transformative...
KFSH&RC Celebrates 25 Scientists Named in Stanford's Top 2% Most-Cited Researchers Worldwide Highlight of the event honoring 25 scientists included...
WÜRZBURG, Germany and CAMBRIDGE, Mass., Jan. 24, 2024 (GLOBE NEWSWIRE) -- DAHW German Leprosy and Tuberculosis Relief Association and BelleTorus...
Acquisition enriches Kyowa Kirin’s portfolio, enables the development of numerous promising candidates with a clinically differentiated platform, and helps to...
Today, 24 January 2024, Coloplast Finance B.V. held its Annual General Meeting at which Ernst & Young Accountants LLP was...
On 24 January 2024, Coloplast Finance B.V. held its Annual General Meeting. At the Annual General Meeting, the sole shareholder,...
Board strengthened with appointments of Tim Haines (Abingworth) as Non-executive Chair and Dr Oliver Nussbaumer (co-founder of GammaDelta Therapeutics and...
PRESS RELEASE Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted...